Hypoxia-inducible factors as molecular targets for liver diseases
Liver disease is a growing global health problem, as deaths from end-stage liver cirrhosis and cancer are rising across the world. At present, pharmacologic approaches to effectively treat or prevent liver disease are extremely limited. Hypoxia-inducible factor (HIF) is a transcription factor that r...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer Berlin Heidelberg
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879168/ |